Skip to main content

Breast Cancer ɛn Osteoporosis: Wetin Yu Nid fɔ No

Breast Cancer ɛn Osteoporosis: Wetin Yu Nid fɔ No

If yu de fɛt wit brɔst kansa, wi no aw di waka kin tranga. We di mɛrɛsin dɛn we dɛn de yuz tide dɔn go bifo, naw dɛn dɔn gɛt tritmɛnt dɛn we rili fayn fɔ mɛn bɔdi kansa. Na dat mek di nɔmba fɔ uman dɛn we de wɛl frɔm kansa de bɔku bak. Bɔt insay dis fɛt, yu kin gɛt ɔda prɔblɛm wit yu wɛlbɔdi prɔblɛm we yu nɔ go no bɔt. Dat min se, bon dɛn kin wik, tan, ɛn i kin brok izi wan. Wi kin kɔl dis na mɛrɛsin ‘Osteoporosis’. Bikɔs bɔku tɛm i kin kam witout ɛni sayn, sɔm pipul dɛn kin kɔl am bak di "saylent disease". So, i rili impɔtant fɔ tich yusɛf bɔt dis.

Wetin na di kɔnekshɔn bitwin bɔdi kansa ɛn di bon we de tan?

Fɔ tɔk am simpul wan, strɔng link de bitwin bɔdi kansa ɛn ɔstioporosis. Dis kin bi bikɔs ɔf sɔm tin dɛn.

Tink bɔt dis: Brɔst kansa kin bɔku pan uman dɛn we dɔn pas 60. Di risk fɔ lɛ dɛn bon dɛn lɔs kin bɔku bak we dɛn ol dis ej. Ɛspɛshali afta we yu dɔn menɔpauz, we di ɛstrojen we de na di bɔdi go dɔŋ. Ɛstrojen na ɔmon we de ɛp fɔ mek wi bon dɛn strɔng. So we dis ɔmon de go dɔŋ, di trɛnk we wi bon dɛn gɛt bak kin bigin fɔ stɔp smɔl smɔl.

Apat frɔm dat, kansa insɛf kin mek di bɔdi inflamɛns. dis de mek di rεt we di ol bon sεl dεm de brok dכn εn slo di rεt we nyu bon sεl dεm de fכm. Dis na ɔda rizin we mek bon dɛn kin wik.

stכdi dεn sho se lεk 80% pan di wan dεm we gεt brεst kεnsar afta mεnoposal de pan risk fכ lכs bon mas.

Aw di tritmɛnt fɔ kansa kin mek di bon dɛn wik?

Nɔto kansa nɔmɔ kin mek di bon dɛn lɔs. Sɔm pan di tritmɛnt dɛm wae dɛn kin gi am kin afɛkt dis bak dairekt wan. Na mɔtalman ɔmon tritmɛnt ɛn kemotɛrapi kin mek di bon dɛn we de na di bɔdi nɔ bɔku. Fɔs, wan sik we dɛn kɔl ɔstiopenia kin apin, we leta kin go bifo to ɔstioporosis.

Di tin we impɔtant pas ɔl na dat, di bon we kin lɔs we pɔsin gɛt kansa , kin apin lɛk sɛvin tɛm fast pas wetin kin apin bay insɛf we pɔsin de ol.

Na lɛk tu-tɛd pan di brɔst kansa dɛn gɛt ɔmon riseptɔ-pɔzitiv. dis min se di kεnsar sεl dεm de mek dεn gro bay כmon dεm lεk εstrojen. So di tritmɛnt fɔ dis sik kin wok bay we dɛn de ridyus di lɛvɛl we di ɛstrojen de na di bɔdi, ɔ bay we dɛn de blok di ɔmon. Pan ɔl we dis impɔtant fɔ kɔntrol di kansa, i sɔri fɔ no se i de pul wi bon dɛn bak di ɛstrojen we dɛn nid.

Lɛ wi luk di tebul we de dɔŋ fɔ si wetin na di men tritmɛnt fɔ kansa we kin afɛkt di bon dɛm.

Di kayn tritmɛnt we dɛn kin gi Aw i kin afɛkt di bon dɛn
Tamoksifen we gɛt di sik Dis drɔg de blok di akshɔn we di ɔmon ɛstrojen de du pan di kansa sɛl dɛn. Pan ɔl we i kin mek di bon dɛn we uman dɛn gɛt smɔl smɔl fɔ mek dɛn bɔdi tan lɛk uman dɛn bifo dɛn menɔpauz, i kin ridyus di prɔblɛm we uman dɛn kin gɛt afta dɛn dɔn menɔpauz.
Aromatase Inhibitɔ dɛn (AI) dɛn . dis dכg dεm (e.g. Anastrozole, Letrozole) de ridyus di bכdi in prodakshכn fכ εstrojen, we de bכku bכku wan inkrεs di risk fכ di bon dεm tכn.
Ɔvarian Sɔpreshɔn di ovaria dεm de stכp fכ prodyuz εstrojen. Dis kin bi fɔ sɔm tɛm wit drɔgs lɛk Goserelin (Zoladex) ɔ fɔ ɔltɛm bay we dɛn de ɔpreshɔn di ovaria dɛn. Dis kin mek di risk fɔ lɛ yu bon dɛn lɔs bɔku.
Kimotɛrapi Pan ɔl we dɛn pawaful mɛrɛsin ya kin kil di kansa sɛl dɛn, dɛn kin pwɛl di ovaria dɛn bak ɛn mek pɔsin nɔ gɛt bɛlɛ we i smɔl, ɛn dis kin mek di bon dɛn we kin tan lɛk tan.

Ɔda tin dɛn we kin mek di prɔblɛm bɔku

We yu de du tritmɛnt fɔ yu bɔdi kansa, yu bon kin tan lɛk se yu bɔdi kin tan lɛk yu bɔdi if dɛn tin ya apin to yu bak:

  • Bikɔs i dɔn pas 65 ia.
  • Fɔ smok.
  • Fɔ drink pasmak ɛvride.
  • Bikɔs i bin dɔn gɛt fraktrɔs bifo.
  • Yuz sterɔyd drɔgs fɔ lɔng tɛm.
  • di bɔdi wet nɔ rich 57 kilogram (125 pawn).

If wan ɔ mɔ pan dɛn tin ya apin to yu, duya mek shɔ se yu tɔk to yu dɔktɔ bɔt yu yon prɔblɛm. Nɔ nid fɔ panik, bɔt i impɔtant fɔ mek yu tɛl yu bifo tɛm.

Aw fɔ chɛk bon wɛlbɔdi?

Yu dɔktɔ kin wach yu bon wɛlbɔdi bifo, di tɛm we yu de trit yu kansa, ɛn afta yu dɔn gɛt kansa. Di men tɛst we dɛn kin yuz fɔ dis na wan DEXA skan .

Dis na tɛst we nɔ de mek pɔsin fil pen, we rili simpul. I tan lɛk spɛshal ɛkstrem rayt. i de mכsu di bon minral dεnsiti na yu spayna εn hip. I fayn fɔ mek dɛn du dis skan bifo yu bigin tritmɛnt ɛn kip am as di beslayn mɛzhɔmɛnt. Dɔn yu kin kɔmpia am leta fɔ si if yu bon dɛn dɔn go dɔŋ.

Di rizulyt fɔ dis tɛst dɛn gi am as T-skɔ. If dis valyu na -2.5 ɔ smɔl pas dat, dɛn kin tek am se na ɔstioporosis ɛn dɛn kin nid fɔ gɛt tritmɛnt.

Us tritmɛnt dɛn kin gi fɔ mek di bon dɛn strɔng?

If yu bon dɛn nɔ bɔku ɔ yu de pan denja fɔ brok, yu dɔktɔ kin gi yu mɛrɛsin fɔ mek yu bon strɔng. Dɛn kin yuz wan tul lɛk di FRAX tul fɔ kɔl yu risk.

Di kayn drɔg we dɛn kin yuz Fɔ wok ɛn ɛgzampul dɛn
Bisfosfonat dɛn Dɛn tin ya kin mek di bon nɔ lɔs ɛn i kin mek di bon dɛn nɔ brok. Dɛn kin gi dɛn as pils ɔ injɛkshɔn we dɛn kin put insay di bɛlɛ. Ɛgzampul dɛn: Alɛndrɔnɛt, Ibandrɔnɛt, Zolɛdronik asid.
Denosumab (Denosumab - Prolia) . Dis na ɔda we fɔ di wan dɛn we nɔ ebul fɔ yuz bisphosphonates. Dɛn kin gi am as injɛkshɔn ɛvri 6 mɔnt. dis kin mek bak di bon tisu dεm we de brok dכn.
Raloksifen (Raloksifen - Evista) we de gi di bɔdi.I de wok lɛk di ɔmon we dɛn kɔl ɛstrojen we de na di bon dɛn, ɛn i de mek dɛn strɔng. Dɛn kin yuse am fɔ protɛkt ɛn trit ɔstioporosis.

Tin dɛn we yu kin du yusɛf fɔ protɛkt yu bon dɛn

Apat frɔm di mɛrɛsin dɛn, if yu chenj di we aw yu de liv yu layf, dat kin ɛp bak fɔ mek yu bon dɛn strɔng.

  • It it wae gɛt bɔku kalsiɔm ɛn vaytamɛn D. Dɛn tu tin ya impɔtant fɔ mek yu gɛt bon. Yu nid lɛk 1000-1200 miligram kalsiɔm ɛn 800-1000 intanashɔnal yunit (IU) vaytamɛn D fɔ wan de. Dɛn tin ya bɔku pan milk ɛn tin dɛn we dɛn mek wit milk, yogɔt, chiz, dak grɛn vɛjitebul dɛn (spinach, kelɛb), ɛn smɔl fish dɛn (lɛk sadin). If yu nɔ gɛt inof frɔm yu it, tink bɔt fɔ tek wan supamakit ɔnda dɔktɔ advays .
  • Du ɛksɛsayz fɔ bia wet. Tin dɛn lɛk fɔ waka, fɔ klaym stej, ɛn fɔ ple tɛnis kin mek yu bon dɛn prɛs ɛn mek dɛn strɔng. Fɔ es wet ɛn yuz rɛsistɛns band dɛn bak na fayn tin.
  • Lɛf fɔ smok ɛn drink rɔm kpatakpata. Dɛn tu tin ya kin mek di bon dɛn wik. Fɔ smok mɔ, i kin mek di bɔdi nɔ ebul fɔ tek di kalsiɔm we de kɔmɔt na di it.

We yu de trit yu kansa ɛn afta yu dɔn gɛt am, ɔltɛm tɔk bɔt yu bon wɛlbɔdi biznɛs wit yu dɔktɔ. Nɔ fred fɔ aks bɔt ɛnitin we de mɔna yu ɔr kwɛstyɔn we yu go gɛt.

Mɛsej we dɛn kin kɛr go na os

  • Brest kansa ɛn sɔm pan in tritmɛnt dɛm (especially hormone therapy) kin mek yu bon dɛm wik ɛn mek yu gɛt ɔstioporosis.
  • Bikɔs dis na "saylent sik," i rili impɔtant fɔ no bɔt dis kwik, pas fɔ wet fɔ mek di sayn dɛm sho.
  • Tɔk to yu dɔktɔ ɛn tink bɔt fɔ du DEXA skan if nid de.
  • Yu kin protɛkt yu bon dɛn bay we yu it it we gɛt bɔku kalsiɔm ɛn vaytamɛn D, du ɛksɛsayz we de mek yu bɔdi wet, ɛn nɔ smok/rɔm.
  • Tɔk opin wan wit yu dɔktɔ bɔt ɛnitin we gɛt fɔ du wit yu wɛlbɔdi, mɔ ɛnitin we de mɔna yu we gɛt fɔ du wit bon wɛlbɔdi.

brɔst kansa, ɔstioporosis, bon wɛlbɔdi, kansa tritmɛnt, DEXA skan, uman dɛn wɛlbɔdi
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 6 + 3 =
Breast Cancer ɛn Osteoporosis: Wetin Yu Nid fɔ No

Breast Cancer ɛn Osteoporosis: Wetin Yu Nid fɔ No

If yu de fɛt wit brɔst kansa, wi no aw di waka kin tranga. We di mɛrɛsin dɛn we dɛn de yuz tide dɔn go bifo, naw dɛn dɔn gɛt tritmɛnt dɛn we rili fayn fɔ mɛn bɔdi kansa. Na dat mek di nɔmba fɔ uman dɛn we de wɛl frɔm kansa de bɔku bak. Bɔt insay dis fɛt, yu kin gɛt ɔda prɔblɛm wit yu wɛlbɔdi prɔblɛm we yu nɔ go no bɔt. Dat min se, bon dɛn kin wik, tan, ɛn i kin brok izi wan. Wi kin kɔl dis na mɛrɛsin ‘Osteoporosis’. Bikɔs bɔku tɛm i kin kam witout ɛni sayn, sɔm pipul dɛn kin kɔl am bak di "saylent disease". So, i rili impɔtant fɔ tich yusɛf bɔt dis.

Wetin na di kɔnekshɔn bitwin bɔdi kansa ɛn di bon we de tan?

Fɔ tɔk am simpul wan, strɔng link de bitwin bɔdi kansa ɛn ɔstioporosis. Dis kin bi bikɔs ɔf sɔm tin dɛn.

Tink bɔt dis: Brɔst kansa kin bɔku pan uman dɛn we dɔn pas 60. Di risk fɔ lɛ dɛn bon dɛn lɔs kin bɔku bak we dɛn ol dis ej. Ɛspɛshali afta we yu dɔn menɔpauz, we di ɛstrojen we de na di bɔdi go dɔŋ. Ɛstrojen na ɔmon we de ɛp fɔ mek wi bon dɛn strɔng. So we dis ɔmon de go dɔŋ, di trɛnk we wi bon dɛn gɛt bak kin bigin fɔ stɔp smɔl smɔl.

Apat frɔm dat, kansa insɛf kin mek di bɔdi inflamɛns. dis de mek di rεt we di ol bon sεl dεm de brok dכn εn slo di rεt we nyu bon sεl dεm de fכm. Dis na ɔda rizin we mek bon dɛn kin wik.

stכdi dεn sho se lεk 80% pan di wan dεm we gεt brεst kεnsar afta mεnoposal de pan risk fכ lכs bon mas.

Aw di tritmɛnt fɔ kansa kin mek di bon dɛn wik?

Nɔto kansa nɔmɔ kin mek di bon dɛn lɔs. Sɔm pan di tritmɛnt dɛm wae dɛn kin gi am kin afɛkt dis bak dairekt wan. Na mɔtalman ɔmon tritmɛnt ɛn kemotɛrapi kin mek di bon dɛn we de na di bɔdi nɔ bɔku. Fɔs, wan sik we dɛn kɔl ɔstiopenia kin apin, we leta kin go bifo to ɔstioporosis.

Di tin we impɔtant pas ɔl na dat, di bon we kin lɔs we pɔsin gɛt kansa , kin apin lɛk sɛvin tɛm fast pas wetin kin apin bay insɛf we pɔsin de ol.

Na lɛk tu-tɛd pan di brɔst kansa dɛn gɛt ɔmon riseptɔ-pɔzitiv. dis min se di kεnsar sεl dεm de mek dεn gro bay כmon dεm lεk εstrojen. So di tritmɛnt fɔ dis sik kin wok bay we dɛn de ridyus di lɛvɛl we di ɛstrojen de na di bɔdi, ɔ bay we dɛn de blok di ɔmon. Pan ɔl we dis impɔtant fɔ kɔntrol di kansa, i sɔri fɔ no se i de pul wi bon dɛn bak di ɛstrojen we dɛn nid.

Lɛ wi luk di tebul we de dɔŋ fɔ si wetin na di men tritmɛnt fɔ kansa we kin afɛkt di bon dɛm.

Di kayn tritmɛnt we dɛn kin gi Aw i kin afɛkt di bon dɛn
Tamoksifen we gɛt di sik Dis drɔg de blok di akshɔn we di ɔmon ɛstrojen de du pan di kansa sɛl dɛn. Pan ɔl we i kin mek di bon dɛn we uman dɛn gɛt smɔl smɔl fɔ mek dɛn bɔdi tan lɛk uman dɛn bifo dɛn menɔpauz, i kin ridyus di prɔblɛm we uman dɛn kin gɛt afta dɛn dɔn menɔpauz.
Aromatase Inhibitɔ dɛn (AI) dɛn . dis dכg dεm (e.g. Anastrozole, Letrozole) de ridyus di bכdi in prodakshכn fכ εstrojen, we de bכku bכku wan inkrεs di risk fכ di bon dεm tכn.
Ɔvarian Sɔpreshɔn di ovaria dεm de stכp fכ prodyuz εstrojen. Dis kin bi fɔ sɔm tɛm wit drɔgs lɛk Goserelin (Zoladex) ɔ fɔ ɔltɛm bay we dɛn de ɔpreshɔn di ovaria dɛn. Dis kin mek di risk fɔ lɛ yu bon dɛn lɔs bɔku.
Kimotɛrapi Pan ɔl we dɛn pawaful mɛrɛsin ya kin kil di kansa sɛl dɛn, dɛn kin pwɛl di ovaria dɛn bak ɛn mek pɔsin nɔ gɛt bɛlɛ we i smɔl, ɛn dis kin mek di bon dɛn we kin tan lɛk tan.

Ɔda tin dɛn we kin mek di prɔblɛm bɔku

We yu de du tritmɛnt fɔ yu bɔdi kansa, yu bon kin tan lɛk se yu bɔdi kin tan lɛk yu bɔdi if dɛn tin ya apin to yu bak:

  • Bikɔs i dɔn pas 65 ia.
  • Fɔ smok.
  • Fɔ drink pasmak ɛvride.
  • Bikɔs i bin dɔn gɛt fraktrɔs bifo.
  • Yuz sterɔyd drɔgs fɔ lɔng tɛm.
  • di bɔdi wet nɔ rich 57 kilogram (125 pawn).

If wan ɔ mɔ pan dɛn tin ya apin to yu, duya mek shɔ se yu tɔk to yu dɔktɔ bɔt yu yon prɔblɛm. Nɔ nid fɔ panik, bɔt i impɔtant fɔ mek yu tɛl yu bifo tɛm.

Aw fɔ chɛk bon wɛlbɔdi?

Yu dɔktɔ kin wach yu bon wɛlbɔdi bifo, di tɛm we yu de trit yu kansa, ɛn afta yu dɔn gɛt kansa. Di men tɛst we dɛn kin yuz fɔ dis na wan DEXA skan .

Dis na tɛst we nɔ de mek pɔsin fil pen, we rili simpul. I tan lɛk spɛshal ɛkstrem rayt. i de mכsu di bon minral dεnsiti na yu spayna εn hip. I fayn fɔ mek dɛn du dis skan bifo yu bigin tritmɛnt ɛn kip am as di beslayn mɛzhɔmɛnt. Dɔn yu kin kɔmpia am leta fɔ si if yu bon dɛn dɔn go dɔŋ.

Di rizulyt fɔ dis tɛst dɛn gi am as T-skɔ. If dis valyu na -2.5 ɔ smɔl pas dat, dɛn kin tek am se na ɔstioporosis ɛn dɛn kin nid fɔ gɛt tritmɛnt.

Us tritmɛnt dɛn kin gi fɔ mek di bon dɛn strɔng?

If yu bon dɛn nɔ bɔku ɔ yu de pan denja fɔ brok, yu dɔktɔ kin gi yu mɛrɛsin fɔ mek yu bon strɔng. Dɛn kin yuz wan tul lɛk di FRAX tul fɔ kɔl yu risk.

Di kayn drɔg we dɛn kin yuz Fɔ wok ɛn ɛgzampul dɛn
Bisfosfonat dɛn Dɛn tin ya kin mek di bon nɔ lɔs ɛn i kin mek di bon dɛn nɔ brok. Dɛn kin gi dɛn as pils ɔ injɛkshɔn we dɛn kin put insay di bɛlɛ. Ɛgzampul dɛn: Alɛndrɔnɛt, Ibandrɔnɛt, Zolɛdronik asid.
Denosumab (Denosumab - Prolia) . Dis na ɔda we fɔ di wan dɛn we nɔ ebul fɔ yuz bisphosphonates. Dɛn kin gi am as injɛkshɔn ɛvri 6 mɔnt. dis kin mek bak di bon tisu dεm we de brok dכn.
Raloksifen (Raloksifen - Evista) we de gi di bɔdi.I de wok lɛk di ɔmon we dɛn kɔl ɛstrojen we de na di bon dɛn, ɛn i de mek dɛn strɔng. Dɛn kin yuse am fɔ protɛkt ɛn trit ɔstioporosis.

Tin dɛn we yu kin du yusɛf fɔ protɛkt yu bon dɛn

Apat frɔm di mɛrɛsin dɛn, if yu chenj di we aw yu de liv yu layf, dat kin ɛp bak fɔ mek yu bon dɛn strɔng.

  • It it wae gɛt bɔku kalsiɔm ɛn vaytamɛn D. Dɛn tu tin ya impɔtant fɔ mek yu gɛt bon. Yu nid lɛk 1000-1200 miligram kalsiɔm ɛn 800-1000 intanashɔnal yunit (IU) vaytamɛn D fɔ wan de. Dɛn tin ya bɔku pan milk ɛn tin dɛn we dɛn mek wit milk, yogɔt, chiz, dak grɛn vɛjitebul dɛn (spinach, kelɛb), ɛn smɔl fish dɛn (lɛk sadin). If yu nɔ gɛt inof frɔm yu it, tink bɔt fɔ tek wan supamakit ɔnda dɔktɔ advays .
  • Du ɛksɛsayz fɔ bia wet. Tin dɛn lɛk fɔ waka, fɔ klaym stej, ɛn fɔ ple tɛnis kin mek yu bon dɛn prɛs ɛn mek dɛn strɔng. Fɔ es wet ɛn yuz rɛsistɛns band dɛn bak na fayn tin.
  • Lɛf fɔ smok ɛn drink rɔm kpatakpata. Dɛn tu tin ya kin mek di bon dɛn wik. Fɔ smok mɔ, i kin mek di bɔdi nɔ ebul fɔ tek di kalsiɔm we de kɔmɔt na di it.

We yu de trit yu kansa ɛn afta yu dɔn gɛt am, ɔltɛm tɔk bɔt yu bon wɛlbɔdi biznɛs wit yu dɔktɔ. Nɔ fred fɔ aks bɔt ɛnitin we de mɔna yu ɔr kwɛstyɔn we yu go gɛt.

Mɛsej we dɛn kin kɛr go na os

  • Brest kansa ɛn sɔm pan in tritmɛnt dɛm (especially hormone therapy) kin mek yu bon dɛm wik ɛn mek yu gɛt ɔstioporosis.
  • Bikɔs dis na "saylent sik," i rili impɔtant fɔ no bɔt dis kwik, pas fɔ wet fɔ mek di sayn dɛm sho.
  • Tɔk to yu dɔktɔ ɛn tink bɔt fɔ du DEXA skan if nid de.
  • Yu kin protɛkt yu bon dɛn bay we yu it it we gɛt bɔku kalsiɔm ɛn vaytamɛn D, du ɛksɛsayz we de mek yu bɔdi wet, ɛn nɔ smok/rɔm.
  • Tɔk opin wan wit yu dɔktɔ bɔt ɛnitin we gɛt fɔ du wit yu wɛlbɔdi, mɔ ɛnitin we de mɔna yu we gɛt fɔ du wit bon wɛlbɔdi.

brɔst kansa, ɔstioporosis, bon wɛlbɔdi, kansa tritmɛnt, DEXA skan, uman dɛn wɛlbɔdi
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 6 + 3 =